27.01.2016
- Geneva, Switzerland-based GAVI (Global Alliance for Vaccines and Immunization), a public-private partnership, and Merck Sharp & Dohme (MSD), known in the US as Merck & Co, have...
26.01.2016
- More than 80 international drug and biotechnology companies have urged governments to work with them to combat the emergence of drug-resistant superbugs, according to a report by...
20.01.2016
- Germany’s Merck KGaA has appointed two new executive board members. Udit Batra and Walter Galinat, heads of the Life Science and Performance Materials business sectors respectively...
18.01.2016
- Germany’s Merck KGaA has won a favorable ruling from the English High Court against Merck, Sharp and Dohme (MSD), known in the US as Merck & Co, over the use of the name Merck...
13.01.2016
- Five major internationally active drugmakers, including American biotech firms Amgen and Celgene, along with pharmaceutical giant Pfizer and non-US players such as Glaxo SmithKline...
12.01.2016
- Globally, mergers and acquisitions at a value of USD 372 billion were recorded in the chemical and pharmaceutical sector in 2015. This amounts to an increase of 74% compared with...
07.01.2016
- Germany’s Merck KGaA and Pfizer of the US are collaborating with US biopharmaceutical company Syndax to evaluate a combination of avelumab and entinostat to treat advanced ovarian...
23.12.2015
- Bayer is likely to seek a major life sciences M&A deal in the next few years, banking sources have told the news agency Reuters. The German group’s absence from a recent wave of...
